North American Aquaculture Vaccines Market size is slated to cross USD 37.7 million by 2027, according to a latest forecast report by Graphical Research.
Rising adoption of aquaculture vaccines by farmers for improving aquaculture framing will be one of the major growth rendering factors of the market. Vaccination improves the yield of aquaculture production along with survival rate. There are various restriction and regulation on use of antibodies for aquaculture in developed countries that will boost the adoption of aquaculture vaccines. However, complex procedure involved in development of vaccine may hamper the market growth.
Development of various advanced and novel vaccines for treatment of viral and bacterial infections during fish farming is the major driving factor of the market. Additionally, companies undertake various strategies such as merger, acquisition to expand product portfolio through sustainable investments and launching new products in the market. Also, companies are investing in R&D programs for innovating vaccines that will drive the market growth.
The live vaccine segmented accounted for USD 3.7 million in 2020. Live vaccines are prepared by one or more bacteria or viruses displaying natural low virulence and attenuated virulence towards the target fish species. They tend to be more immunogenic due to their ability to proliferate or enter host and stimulate greater cellular responses linked to both adaptive and innate immunity. Live vaccines have greater potential to be administered via immersion or oral routes. Attenuated live vaccines have been proved to be safe under most circumstances, thereby propelling the segmental growth.
Browse detailed statistical insights from the report, “North America Aquaculture Vaccines Market Forecast 2027 By Application (Bacterial Infection, Viral Infection), By Type (Inactivated Vaccines, Live Vaccines), By Route of Administration (Immersion Vaccines, Injection Vaccines, Oral Vaccines), By Species (Salmon, Trout, Tilapia), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @
The injection vaccines segment will show a significant growth of 7% during the forecast period. Ease of administration and quick response will augment the injection vaccine segment. Injection vaccines have the ability to treat various viral and bacterial infections at a must faster rate compared to other routes of administration. Advancement in technology and automation will further augment segmental growth during the forecast period.
Bacterial infection segment is expected to reach USD 24.9 million by 2027. Factors such as increasing perveance of the bacterial infection like pseudomonas, streptococcosis and vibriosis and others are the major driving factors that will drive the segmental growth. For instance, yersiniosis is chronic bacterial disease of the intensively cultured salmonids that can cause serious economic losses. This will increase the demand of the usage of aquaculture vaccines for bacterial infections thus, foresting the segmental growth.
Trout segment will show significant growth of 7.1% across the forecast timeframe. Viral Haemorrhagic Septicaemia Virus (VHSV) is an important fish virus that has created several large scale fish kills in both saltwater and fresh fish in farmed and wild fish. VHS is a highly infectious virus disease predominantly affecting rainbow trout in aquaculture. This has led to an increase in the need for developing vaccines against viruses and bacteria that affects trout. Moreover, development of genetically improved trout species for increasing production will further boost business growth in trout vaccines sector.
The U.S. aquaculture vaccines industry will show a significant growth of 7.7% during the forecast period. The country will show significant growth due to adoption of aquaculture vaccines, increasing number of various key players in the country and new vaccine launches. Moreover, there is advancement in technology in aquaculture farming to prevent diseases in marine life that is one of the factors that will propel the market growth in the country.
The North American aquaculture vaccines market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2016 to 2027, for the following segments:
North America Market, By Type
- Inactivated vaccine
- Live vaccine
North America Market, By Route of Administration
- Immersion vaccines
- Injection vaccines
- Oral vaccines
North America Market, By Application
- Bacterial infection
- Viral infection
North America Market, By Species
The above information has been provided for the following countries: